Kashaf Waqar, & Zainab, A. (2022). The tale and trials of Efgartigimod: a newly FDA approved drug for the treatment of Myasthenia gravis. Journal of the Pakistan Medical Association, 72(11), 2366–2367. https://doi.org/10.47391/JPMA.6388